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Abstract
Background:  Analysis of inherited diseases and their associated phenotypes is of great
importance to gain knowledge of underlying genetic interactions and could ultimately give clinically
useful insights into disease processes, including complex diseases influenced by multiple genetic loci.
Nevertheless, to date few computational contributions have been proposed for this purpose,
mainly due to lack of controlled clinical information easily accessible and structured for
computational genome-wise analyses. To allow performing phenotype analyses of inherited
disorder related genes we implemented new original modules within GFINDer  http://
www.bioinformatics.polimi.it/GFINDer/, a Web system we previously developed that dynamically
aggregates functional annotations of user uploaded gene lists and allows performing their statistical
analysis and mining.
Results: New GFINDer modules allow annotating large numbers of user classified biomolecular
sequence identifiers with morbidity and clinical information, classifying them according to genetic
disease phenotypes and their locations of occurrence, and statistically analyzing the obtained
classifications. To achieve this we exploited, normalized and structured the information present in
textual form in the Clinical Synopsis sections of the Online Mendelian Inheritance in Man (OMIM)
databank. Such valuable information delineates numerous signs and symptoms accompanying many
genetic diseases and it is divided into phenotype location categories, either by organ system or type
of finding.
Conclusion: Supporting phenotype analyses of inherited diseases and biomolecular functional
evaluations, GFINDer facilitates a genomic approach to the understanding of fundamental biological
processes and complex cellular mechanisms underlying patho-physiological phenotypes.
Background
Understanding clinical phenotypes through their corre-
sponding genotypes is paramount to unveil inherited
alterations that can lead to pathological processes and
syndromes. However, such comprehension can be very
difficult with complex disorders, which frequently present
different clinical phenotypes that may result from interac-
tions among multiple and potentially unknown genetic
loci. Moreover, considerably different genetic alterations
may cause very similar or even the same phenotype [1,2].
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OMIM Clinical Synopsis section for the Phenylketonuria disease associated with the Phenylalanine Hydroxylase(PAH) human  gene and with Mental retardation Neurologic phenotype Figure 1
OMIM Clinical Synopsis section for the Phenylketonuria disease associated with the Phenylalanine Hydroxy-
lase(PAH) human gene and with Mental retardation Neurologic phenotype. 261600: MIM (Mendelian Inheritance in 
Man) ID of the Phenylketonuria disease; +: in OMIM a plus sign before a MIM number entry indicates that the entry contains 
the description of a gene of known sequence and a phenotype; Neuro: Neurologic, GI: Gastrointestinal, Misc: Miscellaneous, 
Lab: Laboratory phenotype locations.BMC Bioinformatics 2005, 6:S18
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Thus, complex and multivariate analyses of the molecular
processes underlying phenotypically similar disorders are
required to possibly obtain insights into the composite
gene and protein interactions [1]. To computationally
perform such analyses, numerous structured information
and also a few controlled vocabularies that describe bio-
logical processes and molecular functions are available [3-
6].
Nevertheless, useful clinical information related to genetic
diseases is generally not easily accessible and is mainly
included in free text descriptions. Hence, it is not suitably
organized to be used in computational analyses. This lim-
ited availability of controlled structured phenotypic infor-
mation is hampering the development of effective
analytical contributions in the field.
Recently, some tools have been developed to extract
genetic and disease information from free text [7-11].
These, which are based on term co-occurrence and associ-
ation rules or Natural Language Processing techniques,
automatically extract sets of genetic and phenotypic
related terms. However, due to complexity and variety of
clinical biomolecular and genomic descriptions they
inherently present extraction errors, with different degrees
of precision and recall. Therefore, extracted information
should be revised before applying it in subsequent analy-
ses.
In some medical areas, such as oncology, curated pheno-
typic information of complex genetic disorders is being
collected in structured format [12-14]. Nevertheless, cur-
rently such data are only available for few classes of dis-
eases and in quantity not yet enough for computational
genome-wise analyses.
Thus, at present the most important curated, comprehen-
sive, reliable, and updated source of information in
human genetics still remains the Online Mendelian Inher-
itance in Man (OMIM) databank [15,16], which consist of
about 16,100 detailed entries on human genes and
genetic disorders. Although it mainly contains free text
descriptions on genetic loci, inheritance patterns, allelic
variants, biochemical and clinical features, and molecular
and population genetics, many OMIM entries also include
a Clinical Synopsis section that, in structured text format,
outlines disease accompanying signs and symptoms (i.e.
phenotypes) and their locations (Figure 1). Regrettably,
due to the diversity of presentation of human diseases,
and also possibly because OMIM has been in develop-
ment for decades, information in the Clinical Synopsis
sections is not represented in a uniform manner. No con-
trolled vocabulary is used for phenotype and location
names. Several typing errors and synonyms for the same
name, and different names for overlapping concepts are
often present for phenotype location categories (e.g. "Vac-
ular" and "Vascular", "Pre-DX" and "Prenatal diagnosis",
or "Growth" and "Development"), as well as for specific
phenotypes (e.g. "Vestibular function defect" and "Vestib-
ular dysfunction", "Duplication of great toes" and "Dupli-
cated halluces", or "Hypoplastic digits" and "Digital
hypoplasia"), which additionally include a high number
of complex and specific findings. Such variability of used
descriptive names precludes their direct use in automatic
genomic analyses.
To effectively exploit the valuable information in the
OMIM Clinical Synopsis section, we first extracted pheno-
type and their location names and normalized them to
create a term vocabulary describing phenotype and phe-
notype location categories. Then, we hierarchically struc-
tured these category descriptions according to increasing
detail or topological levels. Finally, within GFINDer, a
Web system we previously developed for analyzing
dynamically aggregated annotations of user uploaded
gene lists [17], we used the normalized and structured
Clinical Synopsis vocabularies as basis for new GFINDer
modules specifically devoted to the analysis of inherited
disorder related genes. These new modules allow annotat-
ing large numbers of user classified biomolecular
sequence identifiers with morbidity and clinical informa-
tion, classifying them according to genetic disease pheno-
types and their locations of occurrence, and statistically
analyzing the obtained classifications.
Results
Normalization and structuring of genetic disease 
phenotype and location terms
At time of writing, OMIM contained 16,199 entries, 4,570
of them included a Clinical Synopsis section orderly
divided into phenotype location categories representing
an organ system (e.g. "Endocrine", "Gastrointestinal",
"Respiratory", "Skeletal") or a type of finding (e.g. "Labo-
ratory", "Prenatal manifestation"). Under a location cate-
gory of a specific OMIM genetic disease or locus entry,
they are listed the phenotype manifestations in that loca-
tion known to be associated with the entry. In the OMIM
Clinical Synopsis sections we found 169 different names
of phenotype location categories and 22,609 distinct phe-
notype descriptions. After location name normalization,
we had 94 unique location category terms and 44 syno-
nyms or typographical errors for 32 category terms. This
was obtained by combining, for example, "Lab", "Labora-
tory abnormalities" and "Laboratory" categories into a
unique "Laboratory" category, "Neuro" and "Neurologic"
into the single "Neurologic" category, and by merging
each of the "Ears", "Eyes", "Joints", "Lungs", "Muscles",
and "Limbs" category names with its correspondent sin-
gular category term, respectively. Phenotype description
normalization produced 20,132 unique controlledBMC Bioinformatics 2005, 6:S18
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descriptions, which included 7,898 descriptions inter-
nally subdivided into up to six hierarchical levels of
increasing detail. For example, the phenotype descrip-
tions "Hearing loss, sensorineural, non-progressive, non-
syndromic, congenital, greater mid frequency than low- or
high-frequency loss", "Dysplasia, metaphyseal, marked,
of tubular bones, in childhood", "Deafness, sen-
sorineural, prelingual, profound", "Temperature insensi-
tivity, distal, in some patients", and "Hemolytic anemia,
following ingestion of fava beans" were subdivided and
hierarchically structured into six, five, four, three, and two
hierarchical levels, respectively (Table 1).
Similarly, the normalized 94 unique phenotype locations
resulted hierarchically structured in three topological lev-
els according to their anatomical organization. The main
of such hierarchical levels, which includes broader organ
systems or sites, comprised 36 locations.
All the above normalizations and hierarchical structuring
produced a total of 33,338 phenotype location entries
and 49,072 specific phenotype entries for the available
4,570 OMIM entries with a Clinical Synopsis, which were
annotated to 11,433 distinct genes.
Analysis of inherited disorder phenotypes
GFINDer  [17] is a Web system we previously imple-
mented that dynamically aggregates updated functional
annotations of user-uploaded gene lists from different
databanks and allows performing their comprehensive
explorations and statistical analyses. To this aim, GFINDer
is organized in independent and interconnected modules
that use several controlled vocabularies describing gene
related biomolecular processes and functions. Within
GFINDer, we developed new Genetic Disorder Annotation,
Exploration, and Statistics modules that exploit the pheno-
type and phenotype location vocabularies OMIM pro-
vides and which we normalized and structured. The
Annotation  module produces a tabular output of user-
uploaded gene IDs enriched with related genetic disease
phenotypes and phenotype locations, and with several
other annotations automatically retrieved from many dif-
ferent databanks. The Exploration Genetic Disorders module
(Figure 2) allows to easily and graphically understand
either how many and which phenotype locations and
their specific signs and symptoms are correlated to each
considered gene, or how many of the selected genes refer
to each of those locations, or phenotypes. When uploaded
genes are subdivided in classes (e.g. from clustering anal-
ysis of microarray assay results), the Statistics Genetic Dis-
orders  module allows to estimate relevance of OMIM
controlled annotations for the uploaded classes of genes
by highlighting phenotypic locations and their specific
signs and symptoms significantly more represented
within the user-defined classes of genes. To this aim, the
annotated genes are grouped accordingly to their class and
annotation categories, and their distribution among the
considered categories is statistically evaluated. For this
purpose, different statistical tests and type of corrections
for multiple tests have been implemented in GFINDer, as
following described in the Methods section. After select-
ing a specific gene class, for each inherited disorder anno-
tation category in that class the module provides the
observed number of input genes, their expected number,
and the significance p-value for that category with its his-
togram (Figure 3). External links to the OMIM descrip-
tions and Clinical Synopsis sections related to the
considered genes are also given.
Validation of implemented application
To assess capabilities of implemented GFINDer Genetic
Disorders modules, we used them to evaluate a set of 1,046
human clones spotted on the 7734-1 or 7736-1 Clontech
microarrays [18] focused on cardiovascular system (522
clones) and neurobiology (524 clones), respectively.
Using GFINDer Annotation module we found these clones
corresponded to 935 distinct genes. Out of them, 271
(250 autosomal and 21 X-linked) were involved in 462
inherited diseases, and 122 (97 autosomal and 25 X-
linked) were associated with 679 different phenotypes in
63 locations. Therefore, we used the GFINDer Exploration
and Statistics Genetic Disorders module to evaluate the rel-
evant presence of genes associated with specific inherited
disease phenotypes or locations within the considered
cardiovascular system correlated genes (CARDIO) versus
the neurobiology related genes (NEURO).
With the Exploration module we observed the distribution
of phenotypes and phenotype locations (Figure 2) within
the two considered CARDIO and NEURO classes of genes.
Then, using the Statistics module we evaluated the pheno-
type locations most represented in the CARDIO versus
NEURO class. We concentrated only on genes with phe-
notype location annotations and on location categories
associated with at least two of the considered genes. Sta-
tistical analysis correctly selected phenotype locations
related to the appropriate class of considered genes. In
fact, the significant selected locations included "Cardio-
vascular" (p = 0.00074), "Heme" (p = 0.02206), "Heart" (p
= 0.03165) and "Cardiac" (p = 0.03562) categories for the
CARDIO class, and "Neurologic" (p < 0.00001), "Central
nervous system" (p = 0.0002), "Behavioural/Psychiatric
manifestations" (p = 0.00347), "Peripheral nervous sys-
tem" (p = 0.01702) categories for the NEURO class.
Finally, we analyzed the phenotypes most represented in
the CARDIO versus NEURO class. Focusing only on genes
with phenotype annotations and on phenotype categories
associated with at least two of the considered genes,
GFINDer statistical analysis properly highlighted as mostBMC Bioinformatics 2005, 6:S18
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relevant in each gene class signs and symptoms logically
pertaining to that class (Figure 3). In fact, apart from
inheritance pattern phenotypes, the CARDIO gene class
included "Heart failure congestive" (p  = 0.01402) and
"Hypertension" (p = 0.02271) phenotypes, whereas the
NEURO class included "Dementia" (p = 0.00159), "Myo-
clonus" (p = 0.00677), "Dysarthria" (p = 0.00884) and
"Mental retardation" (p = 0.01557) phenotypes.
Obtained results demonstrate validity of the approach for
the analysis of genetic disorder phenotypes, locations and
related genes that we developed, implemented and made
available within the GFINDer Web system.
Discussion
Our efforts to derive from the OMIM entries a controlled
vocabulary of phenotype locations and descriptions ena-
bled us to normalize and structure the valuable OMIM
phenotypic data according to the obtained vocabulary
and make them suitable for computational use. Although
detailed phenotype descriptions could be further homog-
enized and standardized, their subdivision in hierarchical
levels of detail that we performed allows to group specific
phenotypes according to their common general traits,
without loosing their specific characteristics. So, for exam-
ple "Mental retardation, moderate" and "Mental retarda-
tion, nonspecific" can be both generally considered as
"Mental retardation" and at the same time they can be
treated as different types of mental defects. This provides
the chance to modulate analysis granularity when search-
ing for phenotypic traits shared among multiple diseases
or genotypes. It also ensures more significant and clear
results when categorical statistical analyses are performed
at lower granularity levels of detail. Such interesting fea-
ture, proper of the hierarchical structure and hence
belonging also to the defined phenotype location hierar-
chy, is exploited in the new GFINDer Genetic Disorders
modules implemented for the study of genetic disorder
related genes.
In the Exploration module, the user can select the detail
level of phenotype description, or topological location, at
which exploring the genetic disorder phenotypic annota-
tions associated with a considered set of genes, or explore
all levels at the same time (Figure 2). In the Statistics mod-
ule, consecutive statistical tests are executed on each cate-
gorical annotation independently on its level of detail.
Then, analysis results are shown listing each tested cate-
gorical annotation with its hierarchical level and the
obtained p-value (Figure 3). This simultaneously provides
a comprehensive view of the statistical significance of all
considered annotations and clearly highlights the pheno-
typic characteristics with lowest p-value within each of the
considered user-defined classes of genes, specifying also
their granularity level. Validation results showed that the
above is correctly performed also when genes in different
considered classes are associated with the same genetic
disorder phenotypes, as it happens for disorders that may
have a cardiovascular and neurological etiology. In these
cases, although obtained p-values do not reach statistical
significance, lower p-values properly indicate more rele-
vant phenotypic characteristics (Figure 3).
GFINDer, which is freely available on-line for non-profit
use at http://www.bioinformatics.polimi.it/GFINDer/, is
hence a unique valuable tool that provides support for a
phenotypic taxonomy of inherited diseases. Although sev-
eral tools are available for the analysis of gene annotations
according to the Gene Ontology and few other controlled
Table 1: Hierarchical structure of some of the phenotype 
categories considered in GFINDer, as derived from the 
correspondent phenotype descriptions provided by OMIM 
databank.
Phenotype
Aphasia
Biliary atresia
extrahepatic
Bleeding diathesis
Cardiomyopathy
Coarse facies
Deafness
sensorineural
prelingual
profound
Edema
Elevated IgA
Femoral bowing
present at birth
straightening with time
Gastric ulcer
Hallux valgus
Hemolytic anemia
following ingestion of fava beans
Hypertension
Mental retardation
Pain insensitivity
distal
Psychosis
Ptosis
Quadriplegia
episodic
Recurrent sinusitis
Renal failure
reversible
Seizure
Severe ataxia
Temperature insensitivity
distal
in some patientsBMC Bioinformatics 2005, 6:S18
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vocabularies, at present to our knowledge none supports
phenotype analyses.
Conclusion
Our normalization and structuring of the valuable pheno-
typic information that OMIM offers generated a control-
led phenotypic vocabulary suitable for computational
purposes. As our validation demonstrated, its use within
the new-implemented GFINDer modules allows effective
phenotypic analyses of inherited disorders related genes.
The new GFINDer functionalities can hence help in better
interpreting high-throughput gene lists and in unveiling
new biomedical knowledge about the considered genes.
Thus, they can facilitate a genomic approach in the under-
standing of fundamental biological processes and com-
plex cellular mechanisms, underlying patho-physiological
phenotypes, through their corresponding genotypes.
Methods
Normalization and structuring of genetic disease 
phenotype and location terms
From the omim.txt file, which contains the entire free text
of the OMIM databank and is freely available from the
OMIM FTP site [19], by using standard text-parsing proce-
dures we extracted phenotype descriptions and phenotype
location names included in its Clinical Synopsis sections.
Then, the isolated names and descriptions were visually
inspected and normalized. A unique term was assigned to
each location synonym or incorrect written name. Pheno-
type descriptions were corrected for typo errors and differ-
ent descriptions for the same sign or symptom were
uniformed to the same most recurrent or most correct
description. Furthermore, when phenotype descriptions
included general illustrative terms together with more
specific traits, we subdivided them into hierarchical levels
according to their increasing degree of detail. Similarly,
we hierarchically structured also phenotype locations. In
the available OMIM Clinical Synopsis sections, pheno-
type locations are partially and inconsistently structured
according to their topological organization (Figure 1).
After location term normalization, we homogenized the
provided structure and organized it in hierarchical levels
in relation to the anatomical organization of the
described location categories.
Implemented GFINDer architecture for phenotype 
annotation analyses
GFINDer Web system is implemented in a three-tier archi-
tecture based on a multi-database structure. In the first
tier, the data tier, a MySQL DBMS manages all considered
genomic annotations stored in different relational data-
bases. In this tier, we added a specifically designed rela-
tional database where we hierarchically structured
information about genetic disease phenotypes by exploit-
ing the multi-granular level and topological descriptions
of OMIM Clinical Synopsis phenotypes and phenotype
locations, respectively. To associate an inherited disorder
phenotype with the involved genes or genetic loci, if any,
we considered the MIM codes associated with a gene, as
provided by the Entrez Gene database [3]. Using Java pro-
gramming language, we implemented procedures able to
GFINDer Statistics Genetic Disorders module: phenotypes most  significantly over- and under-represented in the considered  cardiovascular system versus neurobiology gene classes Figure 3
GFINDer Statistics Genetic Disorders module: pheno-
types most significantly over- and under-represented 
in the considered cardiovascular system versus neu-
robiology gene classes. Phenotype level: level in the 
defined phenotype hierarchy (higher levels correspond to 
more detailed and specific phenotype descriptions); P-value-
test-type: P value defining association between a given pheno-
type and a considered class of genes, and initial of used 
statistical test name (h: hypergeometric distribution test).
GFINDer Exploration Genetic Disorders module: phenotype  location categories related to the considered cardiovascular  system and neurobiology genes, respectively Figure 2
GFINDer Exploration Genetic Disorders module: phe-
notype location categories related to the considered 
cardiovascular system and neurobiology genes, 
respectively. Phenotype view: link to the list of considered 
genes associated with phenotypes in the specific Phenotype 
location; Level: level in the defined phenotype location hier-
archy (higher levels correspond to more specific locations); 
Num. (%): absolute and percentage number of considered 
genes associated with phenotypes in the specific phenotype 
location.BMC Bioinformatics 2005, 6:S18
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automatically import and keep updated, in the GFINDer
data tier, genetic disorder phenotype information and cor-
respondent gene annotations, as soon as new releases of
them become available in OMIM and Entrez Gene data-
banks. According to the defined controlled vocabulary of
phenotype descriptions and phenotype location terms,
specific procedures automatically normalize and structure
previously revised annotations included in the latest
imported release of OMIM Clinical Synopsis information.
When novel Clinical Synopsis annotations are included in
a new imported release, an advisory email is automati-
cally sent to the GFINDer phenotype vocabulary supervi-
sor who can use specifically designed GFINDer  Web
interfaces to review and, if required, normalize and struc-
ture the retrieved new annotations.
In GFINDer processing tier we used Microsoft ActiveX Data
Object technology and Standard Query Language to inter-
act with the MySQL DBMS server on the data tier, and
implemented management and analysis routines in Java-
script and Active Server Page scripts. Created analysis pro-
cedures include statistical categorical analyses based on
the normalized lists of unique phenotype and location
category terms. They employ different tests to assess statis-
tical significance of the over and under representation of
categorical phenotypic annotations in a group of user-
classified genes.
In GFINDer user tier, which is composed of any client
computer connected to the Web server on the processing
tier  through an Internet/intranet communication net-
work, we employed Hyper Text Markup Language and
Javascript to implement a Web graphic interface for the
new developed Genetic Disorder modules.
Statistical analysis
Statistical techniques were used in our approach imple-
mented in GFINDer for analyzing genetic disorder pheno-
types and their locations. Because a gene may or may not
be associated with a certain phenotype category defined in
the used controlled vocabulary, the number of genes and
their frequency, distribution, and probability of occur-
rence is calculated for each phenotype category related to
a considered gene set. Several different statistical tests can
be used to calculate a probability value of having x genes
or fewer associated with a given phenotype category. In
GFINDer the hypergeometric test (more time-consuming),
the binomial test (which is an asymptotic limit of the first
for high number of genes), and the exact Fisher test (based
on a two-way table crossing gene classes and phenotype
categories) were implemented [17,20,21]. As usual in all
significance tests, small p-values relate to relevant pheno-
type categories for a certain class of genes. However,
depending on the number of considered genes and their
associated phenotype annotations, the number of per-
formed statistical tests can be high. This can greatly
increase the Type-I error associated to the tests, i.e. the
probability of obtaining a significant p-value by chance
when the null hypothesis is true (or the false-positive
value, as it is known in the medical field). This requires
corrections on the calculated p-values in order to obtain
proper significances.
In GFINDer several correction methods for multiple tests
have been included. The simplest and most strict is the
Bonferroni method that can be applied if the performed
tests are independent [22]. It consists on changing the
threshold α of each single test, from which every corre-
sponding p-value of each test is considered significant, in
such a way that the Type-I error of the whole set of tests is
maintained. The correction is the following αcorrected = α /
N, where N is the number of performed tests. From a prac-
tical point of view this is equivalent to keep the usual
threshold α for the performed tests and apply a correction
to the observed p-values such that pcorrected = N * p. How-
ever, the Bonferroni method greatly reduces the power of
detecting a specific hypothesis when the number of tests
increases. False Discovery Rate (FDR) and Family-Wise
Error-rate (FWE), an extension of Bonferroni method, are
milder corrections and they are even suitable when inde-
pendence among tests does not hold [23]. The former
briefly consists in ordering the N p-values such that the
maximum has rank N and the minimum has rank 1. Then,
the correction to be applied is pcorrected = p * N / rank(p),
except for the maximum p-value that is not corrected. The
latter instead, in the implementation proposed by Ben-
jamini and Hochberg [23], uses the following p-value cor-
rection: pcorrected = p * (N - rank(p) + 1). All three methods
above illustrated are available in GFINDer. Among them
the FDR, which is the mildest of the three and practically
consists in defining the maximum acceptable number of
obtained false-positive tests, is considered the most suita-
ble correction method to be applied on genomic data.
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